Ascent Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $693K | Sell |
1,319
-5
| -0.4% | -$2.63K | 0.03% | 404 |
|
|
2025
Q1 | $840K | Buy |
1,324
+937
| +242% | +$594K | 0.04% | 356 |
|
|
2024
Q4 | $276K | Sell |
387
-83
| -18% | -$59.1K | 0.02% | 463 |
|
|
2024
Q3 | $494K | Sell |
470
-35
| -7% | -$36.8K | 0.04% | 376 |
|
|
2024
Q2 | $531K | Hold |
505
| – | – | 0.04% | 352 |
|
|
2024
Q1 | $486K | Sell |
505
-223
| -31% | -$215K | 0.04% | 362 |
|
|
2023
Q4 | $689K | Sell |
728
-37
| -5% | -$35K | 0.07% | 301 |
|
|
2023
Q3 | $612K | Sell |
765
-2,084
| -73% | -$1.67M | 0.07% | 290 |
|
|
2023
Q2 | $2.22M | Buy |
2,849
+1,034
| +57% | +$807K | 0.24% | 121 |
|
|
2023
Q1 | $1.49M | Buy |
1,815
+299
| +20% | +$246K | 0.16% | 178 |
|
|
2022
Q4 | $1.09M | Buy |
1,516
+117
| +8% | +$84.4K | 0.13% | 209 |
|
|
2022
Q3 | $1.05M | Buy |
1,399
+459
| +49% | +$344K | 0.13% | 203 |
|
|
2022
Q2 | $547K | Buy |
940
+334
| +55% | +$194K | 0.07% | 288 |
|
|
2022
Q1 | $423K | Buy |
606
+92
| +18% | +$64.2K | 0.05% | 347 |
|
|
2021
Q4 | $319K | Buy |
+514
| New | +$319K | 0.04% | 369 |
|